Petroleum-Based Products in Canine Nasal Hyperkeratosis and Digital Skin Care: Why They're Suboptimal
1. Clinical Context: Nasal and Digital Hyperkeratosis in Dogs
Hyperkeratotic changes of the nasal planum and paw pads are common incidental findings but can progress to clinically relevant discomfort, fissuring and secondary infection. They are associated with:
- Age-related keratinisation disorders.
- Brachycephalic conformation and chronic environmental exposure.
- Underlying atopic or immune-mediated disease in some patients.
Although often considered cosmetic, these lesions can negatively impact patient comfort and quality of life, particularly when accompanied by surface fissures and persistent dryness.
2. Canine Nasal and Digital Epidermis: Structural Considerations
The canine nasal planum and digital pads differ significantly from human glabrous skin:
- Highly keratinised epithelium with rapid turnover and limited sebaceous contribution.
- Altered lipid composition and lower reservoir of intercellular lipids compared with human skin.
- Continuous exposure to environmental variables (UV, temperature, humidity, mechanical abrasion).
- Frequent self-grooming and licking, especially at the nasal planum and interdigital spaces.
As a result, products designed for human epidermis cannot be assumed to be appropriate therapeutic agents for canine nasal and digital tissues.
3. Limitations of Petroleum-Based Occlusives in Dogs
A. Complete Occlusion and Microenvironment Disruption
Petroleum jelly provides near-complete occlusion of the stratum corneum. While this can reduce transepidermal water loss (TEWL) in people, in dogs it may:
- Trap heat, environmental debris and micro-organisms at the skin surface.
- Exacerbate maceration of hyperkeratotic plaques on the nasal planum.
- Interfere with normal desquamation and scaling dynamics.
B. Lack of Barrier-Repair Constituents
Hydrocarbon-based products do not contain:
- Biomimetic lipids (e.g. ceramide analogues, physiologic fatty acids).
- Humectants such as urea or glycerin.
- Keratinocyte-supportive or soothing botanical ingredients.
Consequently, they occlude without actively supporting barrier repair or normalisation of keratinisation.
C. Licking Behaviour and Ingestion
The canine nasal planum is routinely moistened through licking. Application of a greasy, persistent hydrocarbon base increases the likelihood of ingestion and repeated self-trauma. While acute toxicity is unlikely at small doses, chronic licking:
- May contribute to mild gastrointestinal disturbance in some patients.
- Reinforces a cycle of grooming and frictional irritation.
D. Functional Impact on Paw Pads
Paw pads rely on a balance between toughness and elasticity. Prolonged, strong occlusion can overly soften the pad surface, potentially:
- Reducing mechanical resilience.
- Predisposing to microfissures and surface trauma.
- Altering gait in painful or severely affected patients.
4. Clinical Presentation: Nasal Hyperkeratosis (Case Illustration)
The following case images illustrate the type of nasal planum changes frequently seen in practice.
5. Sensiderm® Balm: Formulation and Field Data
Sensiderm® Balm (MP Labo) is a veterinary skincare product developed for dry, thickened and hyperkeratotic areas (e.g. nasal planum, pads, calluses). Its formulation combines:
- Humectants: urea, glycerin, shea butter to support hydration.
- Soothing components: Centella asiatica, provitamin B5 (panthenol).
- Renewal support: allantoin and Acacia extract.
- Plant-based occlusive agents: providing semi-occlusion without petroleum derivatives.
Field Study in Dogs with Nasal Hyperkeratosis
A prospective field study in 20 dogs with nasal thickening evaluated the use of Sensiderm® Balm applied twice daily for 60 days. Investigators and owners independently scored dryness, crusting, lichenification and affected area at D0, D30 and D60.
- Combined clinical scores decreased significantly at D30 and D60 versus baseline.
- Owner assessments mirrored investigator-improvement trends.
- Owners reported improved comfort in affected dogs.
- No adverse effects were observed during the study period.
- Read the full poster: /shared/images/content/bus_56348/pdf/2023_Viaud_NKD_scoring_WSAVA_poster_print.pdf
Sensiderm® Balm is a dermatological skincare product, not a medicine. Clinical decisions should be based on the overall presentation and differential diagnosis in each individual case.
6. Integrating Barrier-Supportive Balms Into Clinical Practice
In many patients with non-ulcerative nasal hyperkeratosis or digital thickening, there is an opportunity to complement diagnostic workups and systemic management with barrier-supportive topical care. In practice, this can include:
- Regular assessment and documentation of nasal and digital lesions (including photographs where useful).
- Educating owners on avoiding inappropriate household products such as petroleum jelly.
- Using veterinary-formulated balms with humectants, soothing agents and biomimetic lipids.
- Re-evaluating patients if lesions progress, ulcerate, or if systemic signs develop.
Key Take-Home Messages for Clinicians
Accessing Sensiderm® Balm & Further Clinical Resources
Sensiderm® Balm is available through all major UK veterinary wholesalers, including NVS, MWI and Covetrus, as well as directly from Samaxia at www.samaxia.com/products.
Veterinary professionals can also access detailed product information, clinical resources, training content and CPD updates by registering for the Samaxia Vet Portal.


